Adverse events | AQ+SP (n = 396) | AS+AQ (n = 362) | AL (n = 362) |
---|---|---|---|
Coryza | 10.0% | 12.2% | 13.1% |
Cough | 14.7% | 22.8% | 20.9% |
Anorexia* | 10.3% | 9.7% | 5.5% |
Weakness†| 9.7% | 6.5% | 3.1% |
Abdominal pain | 6.0% | 3.3% | 3.4% |
Vomiting | 3.8% | 1.7% | 1.9% |
Subjective fever | 24.9% | 22.8% | 24.2% |
Headache | 1.5% | 2.8% | 3.4% |
Rash | 6.0% | 5.5% | 4.7% |
Generalized pruritus | 7.4% | 8.2% | 6.5% |
Diarrhoea‡ | 0.7% | 1.1% | 3.2% |
Elevated temperatureγ | 4.8% | 4.5% | 9.2% |
Nausea | 1.0% | 0.3% | 0.3% |
Hepatosplenomegaly | 0.3% | 0.3% | 0.3% |